ATLASiShares MSCI EAFE ETF (EFA): outlook, holdings and fees
iShares MSCI EAFE ETF (EFA) is an exchange-traded fund and is managed by iShares. The expense ratio is 0.31% and the yield is 3.28%. The ten largest holdings are 14% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on EFA
| Last price | $103.80 (+0.4%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 57% |
| Likely 1-month range (50%) | $102.09 – $106.63 |
| Normal 1-day range (±1σ) | ±0.7% |
| Distribution yield | 3.28% · half-yearly |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
EFA fund facts
| Issuer | iShares |
|---|---|
| Theme | International developed |
| Assets under management | $76.5B |
| Expense ratio | 0.31% |
| Number of holdings | 656 |
| Portfolio turnover | 2% |
| Inception | Aug 14, 2001 |
| Exchange | NYSE |
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index is a free float-adjusted, market capitalization-weighted index designed to measure large- and mid-capitalization equity market performance of developed markets outside of the U.S. and Canada.
EFA top holdings
| Holding | Sector | Weight |
|---|---|---|
| ASML Holding N.V. ASML | Technology | 3.42% |
| HSBC Holdings PLC HSBA | Financial Services | 1.49% |
| Roche Holding AG ROP | Healthcare | 1.45% |
| Shell plc SHEL | Energy | 1.31% |
| Novartis AG NOVN | Healthcare | 1.29% |
| AstraZeneca PLC AZN | Healthcare | 1.13% |
| Nestle S.A. NESN | Consumer Defensive | 1.15% |
| Mitsubishi UFJ Financial Group Inc 8306 | Financial Services | 1.07% |
| Siemens Aktiengesellschaft SIE | Industrials | 1.04% |
| SAP SE SAP | Technology | 1.06% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
EFA sector breakdown
| Sector | Weight |
|---|---|
| Financial Services | 25.8% |
| Industrials | 18.5% |
| Technology | 12.2% |
| Healthcare | 9.9% |
| Consumer Cyclicals | 7.1% |
| Consumer Defensive | 6.5% |
| Basic Materials | 6.0% |
| Communication Services | 4.7% |
| Energy | 4.2% |
| Utilities | 3.6% |
| Real Estate | 1.6% |
By region: Europe Developed 47.5%, Japan 25.4%, United Kingdom 14.0%, Australasia 6.8%, Asia Developed 3.6%.
EFA returns and risk
| Year to date | +9.7% |
|---|---|
| 1 year | +13.2% |
| 3 years (annualised) | +17.8% |
| 5 years (annualised) | +8.8% |
| 10 years (annualised) | +9.4% |
| Volatility (3 years) | 12.3% |
| Sharpe ratio (3 years) | 1.04 |
Past returns do not guarantee future results.
EFA: frequently asked questions
What does EFA invest in?
iShares MSCI EAFE ETF invests in a portfolio of securities. Its largest holdings are ASML Holding N.V. (3.4%), HSBC Holdings PLC (1.5%), Roche Holding AG (1.4%), Shell plc (1.3%), Novartis AG (1.3%).
What is the EFA expense ratio?
0.31% a year: about $31.00 for every $10,000 invested.
What is the EFA dividend yield?
3.28%, paid half-yearly. ATLAS does not hold the exact distribution dates for ETFs.
Will EFA go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 57%, with a likely range (50%) of $102.09 to $106.63 from $103.80 today. It is a probability, not a prediction.
How has EFA performed?
Year to date +9.7%, one year +13.2%, three years +17.8% a year, five years +8.8% a year. Past returns do not guarantee future results.
Similar ETFs: International developed
- Vanguard FTSE Developed Markets ETF (VEA)
- iShares Core MSCI EAFE ETF (IEFA)
- Vanguard Total International Stock ETF (VXUS)
- Vanguard FTSE All-World ex-US Index Fund ETF Shares (VEU)
- Schwab International Equity ETF (SCHF)
- iShares Core MSCI Total International Stock ETF (IXUS)
- State Street SPDR Portfolio Developed World ex-US ETF (SPDW)
- iShares Core MSCI International Developed Markets ETF (IDEV)
Educational information, not investment advice. Disclaimer